F. Trudzinski (Homburg (Saar), Germany), J. Fingleton (Wellington, New Zealand)
Late Breaking Abstract - Differences in forced oscillation measurements in different ventilatory defects
S. Kostorz-Nosal (Katowice, Poland), D. Jastrzebski (Katowice, Poland), D. Ziora (Katowice, Poland)
|   |
Automated volumetric quantification of lung emphysema: comparative analysis of different software products results.
N. Griva (Saint-Petersburg, Russian Federation), P. Gavrilov (Saint-Petersburg, Russian Federation)
| |
Triple therapy with Fluticasone furoate/Umeclidinium/Vilanterol compared with dual bronchodilation or triple therapy with inhaled corticosteroids/dual bronchodilation in patients with chronic obstructive pulmonary disease
N. Harada (Kawasaki, Japan), K. Otsuka (Kawasaki, Japan), A. Horiuchi (Kawasaki, Japan), Y. Shinka (Kawasaki, Japan), H. Yamamura (Kawasaki, Japan), N. Miyao (Kawasaki, Japan)
| |
The clinical characteristics of eosinophilic chronic obstructive pulmonary disease:A cohort study
Y. Lin (Yunlin County, Taiwan), S. Chang (Yunlin County, Taiwan), Y. Chen (Yunlin, Taiwan)
| |
The clinical importance of centrilobular enfisema in COPD patients: its impact on the BODE index.
R. Plana Bolba (Lleida, Spain), A. Montcusi Moix (Lleida, Spain), S. Santisteve (Lleida, Spain), J. De Torres Tajes (Kingston, Canada), F. Barbe Illa (Lleida, Spain), J. González Gutiérrez (Lleida, Spain)
| |
The differences between Helium Dilution and Body Plethysmography and its relationship with airway resistance
M. D'Ascanio (Roma (RM), Italy), F. Viccaro (Roma (RM), Italy), N. Calabro (Roma (RM), Italy), D. Pizzirusso (Roma (RM), Italy), G. Guerrieri (Roma (RM), Italy), C. Salvucci (Roma (RM), Italy), A. Ricci (Roma (RM), Italy)
| |
The role of neutrophil/lymphocyte ratio in acute exacerbations of chronic obstructive pulmonary disease COPD
B. Basina (Dnipropetrovsk, Ukraine), L. Konopkina (Dnipropetrovsk, Ukraine)
| |
Sputum rheology and bacteriology in stable and exacerbated chronic obstructive pulmonary disease
W. Chen (Basel, Switzerland), D. Schumann (Basel, Switzerland), M. Tamm (Basel, Switzerland), D. Stolz (Basel, Switzerland)
| |
Relationship between serum levels of testosterone and the severity of chronic obstructive pulmonary disease
A. Slim (Tunis, Tunisia), A. Hedhli (Tunis, Tunisia), M. Mjid (Tunis, Tunisia), Y. Ouahchi (Tunis, Tunisia), S. Cheikh Rouhou (Tunis, Tunisia), J. Cherif (Tunis, Tunisia), S. Toujani (Tunis, Tunisia), S. Merai (Tunis, Tunisia)
| |
Prognostic markers of COPD patients followed by 10 years in a specialized center in Brazil.
J. Fortes Cré (São Paulo, Brazil), A. Borges Amaral (São Paulo, Brazil), L. Buassali Fredini (São Paulo, Brazil), L. Polito Bianchini (São Paulo, Brazil), S. Quaranta Damião (São Paulo, Brazil), A. Consuli Alvarez (São Paulo, Brazil), G. Meira Sacardo (São Paulo, Brazil), E. Fiss (São Paulo (SP), Brazil), M. Silveira Lapa (São Paulo (SP), Brazil)
| |
Prediction of vascular-platelet hemostasis disorders in patients with chronic obstructive pulmonary disease (COPD)
Y. Huba (Dnipro, Ukraine), V. Yakovlieva (Tryskaviec, Ukraine), L. Konopkina (Dnipro, Ukraine)
| |
Radiological prevalence of emphysema on low dose computed tomography(LDCT) in ever-smokers with a normal spirometry
L. Pinto (Mumbai (Maharashtra), India), A. Joshi (Mumbai (Maharashtra), India), R. Raju (Mumbai (Maharashtra), India), A. Mahashur (Mumbai (Maharashtra), India)
| |
The Extended Salford Lung Study: an EHR-based extension of the SLS trials
J. Pimenta (Middlesex, United Kingdom), W. Meeraus (Middlesex, United Kingdom), R. Yeatman (Maidenhead, United Kingdom), A. Barth (Milton Keynes, United Kingdom), T. Hjelmbjerg (Maidenhead, United Kingdom), J. Astrom (Middlesex, United Kingdom), L. Jacques (Middlesex, United Kingdom), S. Mccorkindale (Manchester, United Kingdom), M. Fry (Middlesex, United Kingdom)
| |
Low level of serum free triiodothyronine can be a predictor of long-term mortality after COPD exacerbations
J. Milkowska - Dymanowska (Lódz, Poland), P. Laskowska (Lódz, Poland), P. Lacwik (Lódz, Poland), S. Majewski (Lódz, Poland), P. Górski (Lódz, Poland), W. Piotrowski (Lódz, Poland), A. Bialas (Lódz, Poland)
| |
Prevalence of infradiagnosis of COPD in women by screening with a portable COPD-6 device in Primary Care
M. Santibanez (Santander (Cantabria), Spain), J. Lopez Caro (Santander (Cantabria), Spain), E. Arroita (Santander (Cantabria), Spain), J. Sainz (Santander (Cantabria), Spain), F. Gómez (Santander (Cantabria), Spain), P. Gonzalez (Santander (Cantabria), Spain), N. Valle (Santander (Cantabria), Spain), M. Rodríguez (Santander (Cantabria), Spain), M. Hierro (Santander (Cantabria), Spain), M. Astruga (Santander (Cantabria), Spain), M. Gonzalez (Santander (Cantabria), Spain), J. García-Rivero (Santander (Cantabria), Spain)
| |
Benralizumab effectiveness on quality of life of severe eosinophilic asthmatics in real life
C. Quarato (Foggia, Italy), G. Scioscia (Foggia, Italy), D. Lacedonia (Foggia, Italy), M. Venuti (Foggia, Italy), S. Sonia (Foggia, Italy), F. Paolo (Foggia, Italy), M. Colanardi (Foggia, Italy), G. Carpagnano (Bari, Italy), M. Foschino Barbaro (Foggia, Italy)
| |
TLCO is associated with phenomenological ageing markers in COPD patients of the COSYCONET cohort
V. Graf (Munich, Germany), A. Kronseder (Munich, Germany), T. Lucke (Munich, Germany), R. Joerres (Munich, Germany), S. Karrasch (Munich, Germany)
| |
Cognitive decline following an acute exacerbation of COPD (AECOPD)
G. France (Leicester, United Kingdom), M. Orme (Leicester, United Kingdom), N. Greening (Leicester, United Kingdom), M. Steiner (Leicester, United Kingdom), S. Singh (Leicester, United Kingdom)
| |
Pulmonary hemodynamics and clinical manifestations of COPD patients: is there a relationship?
E. Klester (Barnaul (Altai Region), Russian Federation), A. Balitskaya (Barnaul (Altai Region), Russian Federation), K. Klester (Barnaul (Altai Region), Russian Federation), A. Zharikov (Barnaul (Altai Region), Russian Federation), M. Nikolayeva (Barnaul (Altai Region), Russian Federation), V. Elykomov (Barnaul (Altai Region), Russian Federation)
| |